vepdegestrant

Pfizer, Arvinas Post Upbeat Data From Breast Cancer Study
NASDAQ
Thu, 05/16/24 - 09:54 pm
Pfizer
Arvinas
clinical trials
vepdegestrant
Ibrance
breast cancer